Cargando…

Tumor necrosis factor α release in peripheral blood mononuclear cells of cutaneous lupus and dermatomyositis patients

INTRODUCTION: Several studies have reported that TNFα is substantially increased within skin lesions of patients with discoid lupus erythematosus (DLE), subacute cutaneous lupus erythematosus (SCLE) and dermatomyositis (DM) compared to controls. Elevated TNFα has been reported in the sera of some pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nabatian, Adam S, Bashir, Muhammad M, Wysocka, Maria, Sharma, Meena, Werth, Victoria P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3392787/ https://www.ncbi.nlm.nih.gov/pubmed/22217359 http://dx.doi.org/10.1186/ar3549

Ejemplares similares

Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo effects of Lenabasum(TM)
por: Maddukuri, Spandana, et al.
Publicado: (2022)

Correction to: Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo efects of Lenabasum(TM)
por: Maddukuri, Spandana, et al.
Publicado: (2022)

Importance of collaboration of dermatology and rheumatology to advance the field for lupus and dermatomyositis
por: Werth, Victoria P., et al.
Publicado: (2021)

From pathogenesis, epidemiology, and genetics to definitions, diagnosis, and treatments of cutaneous lupus erythematosus and dermatomyositis: A report from the 3(rd) International Conference on Cutaneous Lupus Erythematosus (ICCLE) 2013
por: Schultz, Heather Yarnall, et al.
Publicado: (2015)

Pathophysiology of cutaneous lupus erythematosus
por: Achtman, Jordan C, et al.
Publicado: (2015)

Subacute cutaneous lupus erythematosus and systemic lupus erythematosus associated with abatacept
por: Tarazi, Meera, et al.
Publicado: (2018)

278 Photo validation study using cutaneous dermatomyositis disease area and severity index in dermatomyositis patients
por: Grinnell, M., et al.
Publicado: (2022)

Advancements in the Treatment of Cutaneous Lupus Erythematosus and Dermatomyositis: A Review of the Literature
por: Elhage, Kareem G, et al.
Publicado: (2022)

Emerging Therapies in Cutaneous Lupus Erythematosus
por: Sprow, Grant, et al.
Publicado: (2022)

The systemic management of cutaneous dermatomyositis: Results of a stepwise strategy()()
por: Anyanwu, C.O., et al.
Publicado: (2017)

Assessment and management of the heightened risk for atherosclerotic cardiovascular events in patients with lupus erythematosus or dermatomyositis
por: Keyes, Emily, et al.
Publicado: (2021)

Subacute cutaneous lupus erythematosus versus discoid lupus erythematosus: A challenging diagnosis
por: Kleitsch, Julianne, et al.
Publicado: (2023)

AB018. Myeloid dendritic cells (mDCs) are major producers of interferon-beta in dermatomyositis and increased numbers of mDCs are found in hydroxychloroquine nonresponders
por: Chen, Kristen L., et al.
Publicado: (2021)

Candidate drug replacements for quinacrine in cutaneous lupus erythematosus
por: Yan, Daisy, et al.
Publicado: (2020)

Cardiotrophin-1 Induces Tumor Necrosis Factor α Synthesis in Human Peripheral Blood Mononuclear Cells
por: Fritzenwanger, Michael, et al.
Publicado: (2009)

A review of cutaneous lupus erythematosus: improving outcomes with a multidisciplinary approach
por: Jarrett, Paul, et al.
Publicado: (2019)

Advancing understanding, diagnosis, and therapies for cutaneous lupus erythematosus within the broader context of systemic lupus erythematosus
por: Chen, Kristen L., et al.
Publicado: (2019)

Dermatomyositis in patients with autoimmune blistering diseases()()
por: Patsatsi, Aikaterini, et al.
Publicado: (2019)

Deep Cutaneous Ulcers in Dermatomyositis
por: Nagashima, Takao, et al.
Publicado: (2017)

Cutaneous lupus erythematosus disease assessment: Highlighting CLE outcome measures
por: Gaffney, Rebecca G., et al.
Publicado: (2022)

Comparing dermatologic patient-reported outcome measures in cutaneous lupus erythematosus
por: Sprow, Grant, et al.
Publicado: (2022)

Tumor Necrosis Factor α from Peripheral Blood Mononuclear Cells of IgA Nephropathy and Mesangial Cell Proliferation
por: Lee, Tae-Won, et al.
Publicado: (1994)

Plasma-derived DNA containing-extracellular vesicles induce STING-mediated proinflammatory responses in dermatomyositis
por: Li, Yubin, et al.
Publicado: (2021)

Dermatomyositis associated with hyponatremia and anasarca
por: Grinnell, Madison, et al.
Publicado: (2021)

Drug-induced dermatomyositis after lacosamide: A case report
por: Gaffney, Rebecca G., et al.
Publicado: (2018)

Drug-induced subacute cutaneous lupus erythematosus in previously diagnosed systemic lupus erythematosus patients: A case series
por: Keyes, Emily, et al.
Publicado: (2021)

Environmental triggers of dermatomyositis: a narrative review
por: Bax, Christina E., et al.
Publicado: (2021)

Herbal supplement Spirulina stimulates inflammatory cytokine production in patients with dermatomyositis in vitro
por: Bax, Christina E., et al.
Publicado: (2023)

Dysbiosis in Peripheral Blood Mononuclear Cell Virome Associated With Systemic Lupus Erythematosus
por: Guo, Gangqiang, et al.
Publicado: (2020)

Transcriptomes of peripheral blood mononuclear cells from juvenile dermatomyositis patients show elevated inflammation even when clinically inactive
por: Roberson, Elisha D. O., et al.
Publicado: (2022)

Severe Cutaneous Findings in a Woman with Dermatomyositis
por: Wang, Sean, et al.
Publicado: (2019)

Phosphodiesterase 4 inhibition but not beta-adrenergic stimulation suppresses tumor necrosis factor-alpha release in peripheral blood mononuclear cells in septic shock
por: Link, Andreas, et al.
Publicado: (2008)

Erythromelalgia associated with dermatomyositis: A case series
por: Grinnell, Madison, et al.
Publicado: (2021)

Cutaneous lupus concerns from the patient perspective: a qualitative study
por: Yan, Daisy, et al.
Publicado: (2021)

Disease severity and prophylactic measures in patients with cutaneous lupus erythematosus: results of a worldwide questionnaire-based study
por: Samotij, Dominik, et al.
Publicado: (2018)

Proteome study of cutaneous lupus erythematosus (CLE) and dermatomyositis skin lesions reveals IL-16 is differentially upregulated in CLE
por: Niewold, Timothy B., et al.
Publicado: (2021)

The identification of circular RNAs from peripheral blood mononuclear cells in systemic lupus erythematosus
por: Zheng, Fengping, et al.
Publicado: (2021)

Geospatial Correlation of Amyopathic Dermatomyositis With Fixed Sources of Airborne Pollution: A Retrospective Cohort Study
por: Pearson, David R., et al.
Publicado: (2019)

Lupus skin disease
por: Werth, Victoria P
Publicado: (2014)

Successful Treatment of Cutaneous Lesions of Dermatomyositis with Topical Pimecrolimus
por: Kim, Ji Eun, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_8eqrvsgveiigj6p8iovp72s1ta